Table 6.
Group (n) | Pre-SI, % | Phases of SI (100%—All SI Cases) | SI, % | LO, % | ||
---|---|---|---|---|---|---|
Development/Interphase Transition/Permission | Phlogogenic Stroke 1 |
Depressive | ||||
Control 1 (donors), n = 50 | 0 | 0 | 0 | 0 | 0 | 0 |
Control 2 (elderly people), n = 22 | 0 | 0 | 0 | 0 | 0 | 0 |
Sepsis non-resuscitative on days 1–2, n = 40 | 65.0 | 7.5 | 0 | 0 | 7.5 | 0 |
Sepsis on days 1–2, n = 46 | 21.7 | 41.2 | 58.8 | 0 | 73.9 3 | 23.9 |
Sepsis on days 5–7, n = 13 | 0 | 46.2 | 53.9 | 0 | 100 3,4 | 30.8 |
Septic shock, n = 14 | 0 | 0 | 78.6 | 21.4 | 100 | 71.4 |
Tertiary peritonitis, n = 34 | 17.6 | 75.0 | 25.0 2 | 0 | 82.4 | 29.4 |
Tertiary peritonitis + SS, n = 17 | 0 | 0 | 5.9 2 | 94.1 | 100 | 94.1 |
Multiple injuries on days 1–2, n = 51 | 21.6 | 53.3 | 46.7 | 0 | 76.5 | 21.6 |
Multiple injuries on days 5–7, n = 18 | 44.4 | 50.0 | 50.0 2 | 0 | 55.6 4 | 50.0 |
Note. SI—systemic inflammation; MOD—multiple organ dysfunction; SS—septic shock; LO—lethal outcomes. 1—primary phlogogenic stroke phase (cytokine storm) was determined on the 1st–2nd days of observation; secondary phlogogenic stroke, on the 5th–7th days and thereafter; 2—secondary phlogogenic stroke phase. 3—statistically significant differences in the same nosology group on different days of the study (Chi-square test, p < 0.05); 4—statistically significant differences between the groups “Sepsis 5–7” and “Multiple injuries 5–7” (Chi-square test, p < 0.05).